205 related articles for article (PubMed ID: 18275936)
1. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
[TBL] [Abstract][Full Text] [Related]
2. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells.
Mackenzie GG; Queisser N; Wolfson ML; Fraga CG; Adamo AM; Oteiza PI
Int J Cancer; 2008 Jul; 123(1):56-65. PubMed ID: 18386790
[TBL] [Abstract][Full Text] [Related]
3. Dimeric procyanidins are inhibitors of NF-kappaB-DNA binding.
Mackenzie GG; Delfino JM; Keen CL; Fraga CG; Oteiza PI
Biochem Pharmacol; 2009 Nov; 78(9):1252-62. PubMed ID: 19591805
[TBL] [Abstract][Full Text] [Related]
4. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
[TBL] [Abstract][Full Text] [Related]
5. TNFalpha-induced NF-kappaB activation and cell oxidant production are modulated by hexameric procyanidins in Caco-2 cells.
Erlejman AG; Jaggers G; Fraga CG; Oteiza PI
Arch Biochem Biophys; 2008 Aug; 476(2):186-95. PubMed ID: 18275839
[TBL] [Abstract][Full Text] [Related]
6. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells.
Mackenzie GG; Carrasquedo F; Delfino JM; Keen CL; Fraga CG; Oteiza PI
FASEB J; 2004 Jan; 18(1):167-9. PubMed ID: 14630700
[TBL] [Abstract][Full Text] [Related]
7. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
Bargou RC; Emmerich F; Krappmann D; Bommert K; Mapara MY; Arnold W; Royer HD; Grinstein E; Greiner A; Scheidereit C; Dörken B
J Clin Invest; 1997 Dec; 100(12):2961-9. PubMed ID: 9399941
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
9. The pathogenetic significance of deregulated signal transduction pathways in Hodgkin's disease: the NF-kappaB-AP-1 network.
Scheidereit C
Verh Dtsch Ges Pathol; 2003; 87():79-89. PubMed ID: 16888898
[TBL] [Abstract][Full Text] [Related]
10. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
11. Cocoa procyanidins protect PC12 cells from hydrogen-peroxide-induced apoptosis by inhibiting activation of p38 MAPK and JNK.
Cho ES; Lee KW; Lee HJ
Mutat Res; 2008 Apr; 640(1-2):123-30. PubMed ID: 18272186
[TBL] [Abstract][Full Text] [Related]
12. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
[TBL] [Abstract][Full Text] [Related]
13. Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts.
Nonaka M; Horie R; Itoh K; Watanabe T; Yamamoto N; Yamaoka S
Oncogene; 2005 Jun; 24(24):3976-86. PubMed ID: 15782119
[TBL] [Abstract][Full Text] [Related]
14. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
[TBL] [Abstract][Full Text] [Related]
15. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
16. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R
Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts.
Lee CH; Shieh DC; Tzeng CY; Chen CP; Wang SP; Chiu YC; Huang CY; Hsu CJ; Fong YC; Tang CH
Mol Immunol; 2008 Aug; 45(14):3693-702. PubMed ID: 18621420
[TBL] [Abstract][Full Text] [Related]
19. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]